Listing 1 - 10 of 13 | << page >> |
Sort by
|
Choose an application
This paper describes different business strategies and business modeling theories and implements them for Admesy's Job-Beam technology.
Choose an application
Bacterial leaching --- Bacterial leaching --- Metallurgy. --- Microbiology. --- Biohydrometallurgy --- Single cell --- Environment --- Ibs --- Lixiviation microbienne --- Métallurgie --- Microbiologie --- Environmental aspects. --- Aspect de l'environnement --- Biohydrometallurgy --- Single cell --- Environment --- Ibs --- Lixiviation microbienne --- Métallurgie --- Microbiologie --- Aspect de l'environnement
Choose an application
This work is an investigation of preliminary steps in the microfabrication of titanium nitride microheaters to be integrated under the surface of flight mirrors. This work focuses on the analysis of titanium thin films properties as a function of thickness.
Microheaters --- Titanium nitride --- TiN --- Sputtering --- Ion Beam Sputtering --- IBS --- Laser-Induced Forward Transfer --- LIFT Thin films --- Ingénierie, informatique & technologie > Ingénierie aérospatiale
Choose an application
1 Vol. (2 issues) / year.Comes with "Bulbs".Devoted to the increase and diffusion of knowledge on bulbous plants and petaloid monocot families, especially the Amaryllidaceae.
Botany --- Amaryllidaceae --- Bulbs (Plants) --- Amaryllidaceae. --- Botany. --- Bulb plants --- Bulbous plants --- Bulbs --- Flower bulbs --- Flowering bulbs --- Tuberous-rooted plants --- Perennials --- Amaryllis family (Plants) --- Asparagales --- International Bulb Society --- International Bulb Society. --- IBS --- American Plant Life Society --- Life Sciences
Choose an application
Chronic intestinal diseases are increasing around the world. With poor quality of life and expensive healthcare costs, the patients demand novel approaches and treatments for better clinical outcomes. This book illustrates the state of the art and the envisaged near future in the management of these pathologies.
Medicine --- chronic intestinal pseudo-obstruction --- parenteral nutrition --- pediatrics --- myopathy --- neuropathy --- IBS --- microbiota --- visceral hypersensitivity --- colorectal motility --- inflammatory bowel disease --- Crohn's disease --- ulcerative colitis --- anti-TNF --- ustekinumab --- vedolizumab --- postoperative complications --- surgery --- preoperative therapy --- biologic therapy --- bio-naïve --- IBD --- pro-inflammatory cytokines --- lymphocyte migration --- treatment --- inflammatory bowel diseases --- biologic treatment --- combination --- chronic intestinal pseudo-obstruction --- parenteral nutrition --- pediatrics --- myopathy --- neuropathy --- IBS --- microbiota --- visceral hypersensitivity --- colorectal motility --- inflammatory bowel disease --- Crohn's disease --- ulcerative colitis --- anti-TNF --- ustekinumab --- vedolizumab --- postoperative complications --- surgery --- preoperative therapy --- biologic therapy --- bio-naïve --- IBD --- pro-inflammatory cytokines --- lymphocyte migration --- treatment --- inflammatory bowel diseases --- biologic treatment --- combination
Choose an application
Chronic intestinal diseases are increasing around the world. With poor quality of life and expensive healthcare costs, the patients demand novel approaches and treatments for better clinical outcomes. This book illustrates the state of the art and the envisaged near future in the management of these pathologies.
Medicine --- chronic intestinal pseudo-obstruction --- parenteral nutrition --- pediatrics --- myopathy --- neuropathy --- IBS --- microbiota --- visceral hypersensitivity --- colorectal motility --- inflammatory bowel disease --- Crohn’s disease --- ulcerative colitis --- anti-TNF --- ustekinumab --- vedolizumab --- postoperative complications --- surgery --- preoperative therapy --- biologic therapy --- bio-naïve --- IBD --- pro-inflammatory cytokines --- lymphocyte migration --- treatment --- inflammatory bowel diseases --- biologic treatment --- combination --- n/a --- Crohn's disease --- bio-naïve
Choose an application
Chronic intestinal diseases are increasing around the world. With poor quality of life and expensive healthcare costs, the patients demand novel approaches and treatments for better clinical outcomes. This book illustrates the state of the art and the envisaged near future in the management of these pathologies.
chronic intestinal pseudo-obstruction --- parenteral nutrition --- pediatrics --- myopathy --- neuropathy --- IBS --- microbiota --- visceral hypersensitivity --- colorectal motility --- inflammatory bowel disease --- Crohn’s disease --- ulcerative colitis --- anti-TNF --- ustekinumab --- vedolizumab --- postoperative complications --- surgery --- preoperative therapy --- biologic therapy --- bio-naïve --- IBD --- pro-inflammatory cytokines --- lymphocyte migration --- treatment --- inflammatory bowel diseases --- biologic treatment --- combination --- n/a --- Crohn's disease --- bio-naïve
Choose an application
The only effective and safe treatment of celiac disease (CD) is a lifelong, strict exclusion of gluten, the so-called gluten-free diet (GFD). As a consequence, strict adherence to the GFD is highly successful and useful to achieve optimal control of symptoms in celiac patients, although, sometimes, nutritional problems can persist despite a strict exclusion of gluten. However, following a strict GFD is not easy and an updated quality assessment of available products is needed for further improvement in gluten-free product development. Similar to CD, GFD is the common dietary approach in non-celiac gluten/wheat sensitivity (NCGWS). NCGWS is another common gluten-related disorder without the diagnostic features of CD. Increasing interest in the association and interaction between irritable bowel syndrome (IBS), functional dyspepsia, and gluten-related disorders can expand our knowledge and understanding of the management of these disorders. In this respect, GFD is considered a therapeutic option in IBS and functional digestive disorders. New insights into the GFD are an exciting scientific challenge for researchers.
Research & information: general --- Biology, life sciences --- Food & society --- irritable bowel syndrome --- celiac disease --- nonceliac gluten/wheat sensitivity --- gluten-free diet --- AIDAI score --- amylase trypsin inhibitor --- non-celiac wheat sensitivity --- CD14 lymphocytes --- interleukin-1beta --- tumor necrosis factor-α --- non coeliac wheat sensitivity --- gluten --- FODMAPs --- functional dyspepsia --- Celiac disease --- iron deficiency without anemia --- dietary iron --- iron supplementation --- women --- refractory celiac disease --- remission --- nickel allergy --- allergic contact mucositis --- irritable bowel syndrome (IBS) --- low-nickel diet --- gluten-free products --- gluten containing products --- food composition database --- dietary reference intake --- prison diets --- irritable bowel disease --- FODMAP --- low FODMAP diet --- gluten free diet --- non-celiac gluten wheat sensitivity --- n/a
Choose an application
The only effective and safe treatment of celiac disease (CD) is a lifelong, strict exclusion of gluten, the so-called gluten-free diet (GFD). As a consequence, strict adherence to the GFD is highly successful and useful to achieve optimal control of symptoms in celiac patients, although, sometimes, nutritional problems can persist despite a strict exclusion of gluten. However, following a strict GFD is not easy and an updated quality assessment of available products is needed for further improvement in gluten-free product development. Similar to CD, GFD is the common dietary approach in non-celiac gluten/wheat sensitivity (NCGWS). NCGWS is another common gluten-related disorder without the diagnostic features of CD. Increasing interest in the association and interaction between irritable bowel syndrome (IBS), functional dyspepsia, and gluten-related disorders can expand our knowledge and understanding of the management of these disorders. In this respect, GFD is considered a therapeutic option in IBS and functional digestive disorders. New insights into the GFD are an exciting scientific challenge for researchers.
irritable bowel syndrome --- celiac disease --- nonceliac gluten/wheat sensitivity --- gluten-free diet --- AIDAI score --- amylase trypsin inhibitor --- non-celiac wheat sensitivity --- CD14 lymphocytes --- interleukin-1beta --- tumor necrosis factor-α --- non coeliac wheat sensitivity --- gluten --- FODMAPs --- functional dyspepsia --- Celiac disease --- iron deficiency without anemia --- dietary iron --- iron supplementation --- women --- refractory celiac disease --- remission --- nickel allergy --- allergic contact mucositis --- irritable bowel syndrome (IBS) --- low-nickel diet --- gluten-free products --- gluten containing products --- food composition database --- dietary reference intake --- prison diets --- irritable bowel disease --- FODMAP --- low FODMAP diet --- gluten free diet --- non-celiac gluten wheat sensitivity --- n/a
Choose an application
The only effective and safe treatment of celiac disease (CD) is a lifelong, strict exclusion of gluten, the so-called gluten-free diet (GFD). As a consequence, strict adherence to the GFD is highly successful and useful to achieve optimal control of symptoms in celiac patients, although, sometimes, nutritional problems can persist despite a strict exclusion of gluten. However, following a strict GFD is not easy and an updated quality assessment of available products is needed for further improvement in gluten-free product development. Similar to CD, GFD is the common dietary approach in non-celiac gluten/wheat sensitivity (NCGWS). NCGWS is another common gluten-related disorder without the diagnostic features of CD. Increasing interest in the association and interaction between irritable bowel syndrome (IBS), functional dyspepsia, and gluten-related disorders can expand our knowledge and understanding of the management of these disorders. In this respect, GFD is considered a therapeutic option in IBS and functional digestive disorders. New insights into the GFD are an exciting scientific challenge for researchers.
Research & information: general --- Biology, life sciences --- Food & society --- irritable bowel syndrome --- celiac disease --- nonceliac gluten/wheat sensitivity --- gluten-free diet --- AIDAI score --- amylase trypsin inhibitor --- non-celiac wheat sensitivity --- CD14 lymphocytes --- interleukin-1beta --- tumor necrosis factor-α --- non coeliac wheat sensitivity --- gluten --- FODMAPs --- functional dyspepsia --- Celiac disease --- iron deficiency without anemia --- dietary iron --- iron supplementation --- women --- refractory celiac disease --- remission --- nickel allergy --- allergic contact mucositis --- irritable bowel syndrome (IBS) --- low-nickel diet --- gluten-free products --- gluten containing products --- food composition database --- dietary reference intake --- prison diets --- irritable bowel disease --- FODMAP --- low FODMAP diet --- gluten free diet --- non-celiac gluten wheat sensitivity --- irritable bowel syndrome --- celiac disease --- nonceliac gluten/wheat sensitivity --- gluten-free diet --- AIDAI score --- amylase trypsin inhibitor --- non-celiac wheat sensitivity --- CD14 lymphocytes --- interleukin-1beta --- tumor necrosis factor-α --- non coeliac wheat sensitivity --- gluten --- FODMAPs --- functional dyspepsia --- Celiac disease --- iron deficiency without anemia --- dietary iron --- iron supplementation --- women --- refractory celiac disease --- remission --- nickel allergy --- allergic contact mucositis --- irritable bowel syndrome (IBS) --- low-nickel diet --- gluten-free products --- gluten containing products --- food composition database --- dietary reference intake --- prison diets --- irritable bowel disease --- FODMAP --- low FODMAP diet --- gluten free diet --- non-celiac gluten wheat sensitivity
Listing 1 - 10 of 13 | << page >> |
Sort by
|